Genetically Engineered Cell Lines

Genetically Engineered Cell Lines Overview

genetically engineered cell lines services

With the advancement of gene sequencing and gene editing technologies, an increasing number of new drug targets for cancer are being discovered. Drug testing at the cellular level targeting these new targets is a crucial step in drug discovery and provides valuable insights before progressing to In vivo pharmacology studies for comprehensive therapeutic evaluation. Our expert team has over 20 years of experience in engineering cell lines. We have already constructed over 4,000 genetically edited cell lines, covering a wide range of overexpressed, knocked-in and knocked-out genes related to kinase (based on BaF3 cell line), signaling pathways, immune molecules, tumor antigens, and related targets. Representative models include immune- and antigen-modified variants such as the CT26-TPBG5T4-FLAG cell line, developed to support target validation and therapeutic evaluation studies. These cell lines support the development of both small molecule and antibody-based drugs for cancer treatment, and each gene editing cell line can be used to investigate specific gene functions and therapeutic targets.

Technology

Genetically engineered cell lines revolutionize research, enabling precise studies on diseases, therapies, and biological processes for innovative medical advancements.

In vitro pharmacology explores drug effects in controlled lab settings, while in vivo pharmacology investigates drug responses within living organisms.

Revolutionize immunotherapy with our cutting-edge Bispecific and Tri-specific Antibody Discovery Platform, enhancing precision and efficacy in targeted cancer treatments

Genetically engineered cell lines are transforming research by utilizing membrane screening platforms to conduct detailed studies on diseases, therapies, and biological mechanisms, paving the way for groundbreaking medical advancements.

AI-based antibody development platform for pioneering antibody development, enhancing precision and accelerating discovery in therapeutic research.